Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Stopping immunomodulatory medications in MS: Frequency, reasons and consequences.
Human antigen R binding and regulation of SOX2 mRNA in human mesenchymal stem cells.
Comparison of Disease Activity in SPMS and PPMS in the Context of Multicenter Clinical Trials.
In the coming year we should abandon interferons and glatiramer acetate as first-line therapy for MS: Yes.
Piet Mondrian's trees and the evolution in understanding multiple sclerosis, Charcot Prize Lecture 2011.
Quantitative PCR for Epstein-Barr virus DNA and RNA in multiple sclerosis.
Minocycline in active rheumatoid arthritis. A double-blind, placebo-controlled trial.
Aquaporin-4 Autoantibodies in Neuromyelitis Optica: AQP4 Isoform-Dependent Sensitivity and Specificity.
Electrophysiological features of POEMS syndrome and chronic inflammatory demyelinating polyneuropathy.
Method for the systematic reviews on occupational therapy and neurodegenerative diseases.
Diagnosis and classification of autoimmune optic neuropathy.
Anti-CD20 inhibits T cell-mediated pathology and microgliosis in the rat brain.
Multiple sclerosis: Oral BG12 for treatment of relapsing-remitting MS.
Treg cell resistance to apoptosis in DNA vaccination for experimental autoimmune encephalomyelitis treatment.
Mind-body medicine for multiple sclerosis: a systematic review.
Fibronectin aggregation in multiple sclerosis lesions impairs remyelination.
Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity.
Gene Therapy of Multiple Sclerosis Using Interferon β -Secreting Human Bone Marrow Mesenchymal Stem Cells.
Cost-effectiveness of fingolimod versus interferon beta-1a for relapsing remitting multiple sclerosis in the United States.
Anti-CD25 Immunotherapy: Regulating the Regulators.
Quantitative MRI for Analysis of Active Multiple Sclerosis Lesions without Gadolinium-Based Contrast Agent.
Safety profile of dalfampridine extended release in multiple sclerosis: 5-year postmarketing experience in the United States.
An Overview of Models, Methods, and Reagents Developed for Translational Autoimmunity Research in the Common Marmoset (Callithrix jacchus).
Social support, depression, and physical disability: Age and diagnostic group effects.
Long-term benefits of induction therapy in NMO: a case report.

Pages